Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Rafael Holdings Inc (RFL)

Rafael Holdings Inc (RFL)
0.7840 x 2 2.2000 x 3
Pre-market by (Cboe BZX)
1.9600 -0.0300 (-1.51%) 02/24/25 [NYSE]
0.7840 x 2 2.2000 x 3
Pre-market 1.9600 unch (unch) 19:00 ET
Quote Overview for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.8900
Day High
2.0600
Open 1.9600
Previous Close 1.9900 1.9900
Volume 41,700 41,700
Avg Vol 30,600 30,600
Stochastic %K 50.00% 50.00%
Weighted Alpha +16.91 +16.91
5-Day Change -0.1200 (-5.77%) -0.1200 (-5.77%)
52-Week Range 1.2900 - 2.5000 1.2900 - 2.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,027
  • Shares Outstanding, K 25,014
  • Annual Sales, $ 640 K
  • Annual Income, $ -34,410 K
  • EBIT $ -104 M
  • EBITDA $ -103 M
  • 60-Month Beta 1.12
  • Price/Sales 78.14
  • Price/Cash Flow N/A
  • Price/Book 0.63

Options Overview Details

View History
  • Implied Volatility 221.46% ( -271.17%)
  • Historical Volatility 40.67%
  • IV Percentile 75%
  • IV Rank 41.89%
  • IV High 492.63% on 02/20/25
  • IV Low 25.95% on 09/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 91
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 456
  • Open Int (30-Day) 371

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8600 +5.38%
on 02/07/25
Period Open: 2.1000
2.1200 -7.55%
on 02/18/25
-0.1400 (-6.67%)
since 01/24/25
3-Month
1.5000 +30.67%
on 12/30/24
Period Open: 1.9100
2.1800 -10.09%
on 01/23/25
+0.0500 (+2.62%)
since 11/22/24
52-Week
1.2900 +51.94%
on 07/12/24
Period Open: 1.7100
2.5000 -21.60%
on 10/14/24
+0.2500 (+14.62%)
since 02/23/24

Most Recent Stories

More News
Rafael Holdings, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Updates on Planned Merger with Cyclo Therapeutics

Rafael Holdings reports Q1 fiscal 2025 results, anticipates merger with Cyclo Therapeutics, and focuses on Trappsol® Cyclo™ development.Quiver AI SummaryRafael Holdings, Inc. reported its financial...

RFL : 1.9600 (-1.51%)
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

RFL : 1.9600 (-1.51%)
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

RFL : 1.9600 (-1.51%)
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation...

CYTH : 0.8019 (-11.86%)
RFL : 1.9600 (-1.51%)
Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.

CRANBURY, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.9600 (-1.51%)
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism – UPDATE

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.9600 (-1.51%)
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.9600 (-1.51%)
Rafael Holdings Reports Third Quarter Fiscal 2022 Financial Results

NEWARK, N.J., June 14, 2022 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), an early-stage novel cancer and immune metabolism therapeutics...

RFL : 1.9600 (-1.51%)
Cornerstone Pharmaceuticals to Present Pancreatic Cancer, Clear Cell Sarcoma and Biliary Tract Cancer Research Featuring CPI-613® (Devimistat) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Cranbury, NJ, June 01, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.9600 (-1.51%)
European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals’ CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer

Cranbury, NJ, May 24, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.9600 (-1.51%)

Business Summary

Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.

See More

Key Turning Points

3rd Resistance Point 2.2200
2nd Resistance Point 2.1400
1st Resistance Point 2.0500
Last Price 1.9600
1st Support Level 1.8800
2nd Support Level 1.8000
3rd Support Level 1.7100

See More

52-Week High 2.5000
Fibonacci 61.8% 2.0378
Last Price 1.9600
Fibonacci 50% 1.8950
Fibonacci 38.2% 1.7522
52-Week Low 1.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements